Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. financial statements
Amphastar Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 719.89M | 10-K |
| Net income | USD 98.09M | 10-K |
| Cash and equivalents | USD 170.18M | 10-Q |
| Total debt | USD 621.35M | 10-Q |
Amphastar Pharmaceuticals, Inc. financials on 6ix · Amphastar Pharmaceuticals, Inc. on 6ix